Fig. 2From: Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030Decomposition analysis of changes in the DALY number of pancreatic cancer attributable to (A) high fasting plasma glucose and (B) high body-mass index between 1990 and 2019 across 21 GBD regions. DALY: disability-adjusted life yearBack to article page